LANSOPRAZOLE Safety Questions, LANSOPRAZOLE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about LANSOPRAZOLE. Our extensive database of LANSOPRAZOLE adverse events and LANSOPRAZOLE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about LANSOPRAZOLE
LANSOPRAZOLE Safety Reports
Total LANSOPRAZOLE reports: 137.LANSOPRAZOLE FDA safety alerts: No.
Reported deaths: 40 Reported hospitalizations: 68.
Take LANSOPRAZOLE Side Effects Survey or Share Your LANSOPRAZOLE Story. Read More Here.
Showing 1-75 of 137 Next >
Physician from JAPAN reported LANSOPRAZOLE problem on Aug 07, 2006. Female patient, 74 years of age, was diagnosed with gastric ulcer and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, disseminated intravascular coagulation, multi-organ failure, oliguria, pyrexia, toxic epidermal necrolysis. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with SELBEX, ULCERLMIN, MUCODYNE, LANIRAPID, MUCOSOLVAN, LASIX, ALDACTONE, HALFDIGOXIN. Patient died.LANSOPRAZOLE problem was reported by a Physician from UNITED KINGDOM on Aug 04, 2006. Female patient, 76 years of age, was diagnosed with rheumatoid arthritis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, haemoglobin decreased, neutrophil count decreased, white blood cell count decreased. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with AZAPROPAZONE, METHOTREXATE, FOLIC ACID, FLUCLOXACILIN, BENZYLPENICILLIN, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from MEXICO reported LANSOPRAZOLE problem on Aug 10, 2006. Female patient, 21 years of age, was diagnosed with irritable bowel syndrome and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with ZELMAC. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Aug 14, 2006. Male patient, 62 years of age, was diagnosed with duodenal ulcer perforation, pneumonia and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer haemorrhage, gastrointestinal haemorrhage, haemoglobin decreased, hypoproteinaemia, hypotension, necrosis, oedema, oesophageal stenosis, pleural effusion. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) NASOGASTRIC TUBE. During the same period patient was treated with PAZUCROSS, BIOFERMIN, TARGOCID, PRIMPERAN, GASMOTIN. Patient died.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Aug 18, 2006. Male patient, 71 years of age, was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with BUFFERIN, PANALDINE, HERBESSER R, MUCOSTA. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from MEXICO on Aug 10, 2006. Female patient, 21 years of age, was diagnosed with irritable bowel syndrome and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with ZELMAC. Patient recovered.
Health Professional from AUSTRALIA reported LANSOPRAZOLE problem on Aug 18, 2006. Female patient, 70 years of age, was diagnosed with essential hypertension and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: renal failure acute. LANSOPRAZOLE dosage: 30 MG PER ORAL. During the same period patient was treated with ATACAND HCT, ALLOPURINOL, AVAPRO, CELEBREX, INDAPAMIDE, LIPIDIL, RENITEC, ZANIDIP. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 20, 2006. Female patient, 33 years of age, was diagnosed with depression and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: haematochezia, proctitis ulcerative. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with EFFEXOR, CITALOPRAM HYDROBROMIDE, PULMICORT, CLARITIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Aug 24, 2006. Male patient, 62 years of age, was diagnosed with duodenal ulcer perforation, pneumonia and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer haemorrhage, gastrointestinal haemorrhage, haemoglobin decreased, hypoproteinaemia, hypotension, infusion related reaction, melaena, necrosis, oedema. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) NASOGASTRIC TUBE. During the same period patient was treated with PAZUCROSS, BIOFERMIN, TARGOCID, MAXIPIME, PRIMPERAN, GASMOTIN. Patient died.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from FRANCE on Aug 24, 2006. Female patient, 14 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: microcytic anaemia, pyrexia, renal failure, tubulointerstitial nephritis, urticaria. LANSOPRAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported LANSOPRAZOLE problem on Aug 25, 2006. Female patient, 76 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with AZAPROPAZONE, METHOTREXATE, FOLIC ACID, FLUCLOXACILLIN, BENZYLPENICILLIN, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Aug 28, 2006. Male patient, 71 years of age, was diagnosed with blood creatine phosphokinase increased, reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with BUFFERIN, TICLOPIDINE, DILTIAZEM HYDROCHLORIDE, MUCOSTA. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Sept 01, 2006. Female patient, 90 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative, femoral neck fracture, multi-organ failure. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with ALOSITOL, LASIX. Patient died.
LANSOPRAZOLE problem was reported by a Pharmacist from JAPAN on Sept 08, 2006. Male patient, 65 years of age, was diagnosed with acute myocardial infarction, renal failure chronic, arteriosclerosis obliterans, hypertension and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis obliterans, disease progression, gangrene, sepsis, stevens-johnson syndrome, toxic epidermal necrolysis, urinary tract infection. LANSOPRAZOLE dosage: 30 MG, (30MG, 1 IN 1 D); PER ORAL. During the same period patient was treated with DORNER, TANATRIL, WARFARIN, ASPIRIN, TICLOPIDINE, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient died.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Sept 12, 2006. Male patient, 70 years of age, was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: oculomucocutaneous syndrome. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with LASIX, LOXONIN. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 13, 2006. Female patient, 59 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: confusional state, depression, fatigue, nephritis, pain, pyrexia. LANSOPRAZOLE dosage: 30 MG. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRIA reported LANSOPRAZOLE problem on Sept 14, 2006. Male patient was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, colitis collagenous, diarrhoea, hypertension. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with NSAID. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from AUSTRIA on Sept 21, 2006. Male patient, 66 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abscess intestinal, cardiac failure, colitis collagenous, pulmonary congestion. LANSOPRAZOLE dosage: 30 MG PER ORAL. During the same period patient was treated with NSAID, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Sept 29, 2006. Female patient, 74 years of age, was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: leukoplakia. LANSOPRAZOLE dosage: 15 MG (15 MG, 1D) PER ORAL. During the same period patient was treated with BLOPRESS, ARTIST, ASPIRIN, FLUITRAN, DIAZEPAM. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Oct 06, 2006. Male patient, 78 years of age, was diagnosed with gastrointestinal haemorrhage and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cardiovascular disorder, dehydration, diabetic nephropathy, disease progression, renal disorder, renal impairment, shock. LANSOPRAZOLE dosage: 15 MG (15 MG, 1IN 1D) PER ORAL. During the same period patient was treated with FERROMIA, AMINOFLUJID, LACTEC. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Oct 05, 2006. Female patient, 74 years of age, was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: leukoplakia. LANSOPRAZOLE dosage: 15 MG (15 MG, 1D) PER ORAL. During the same period patient was treated with BLOPRESS, ARTIST, ASPIRIN, FLUITRAN, HORIXON. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Oct 10, 2006. Male patient, 62 years of age, was diagnosed with gastric ulcer and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, haemorrhage, melaena. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with VOLTAREN, METHAPHYLLIN. Patient died.
Consumer or non-health professional from UNITED KINGDOM reported LANSOPRAZOLE problem on Sept 29, 2006. Female patient, 65 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time, anorexia, bone marrow failure, candidiasis, dry mouth, dysphagia, hepatosplenomegaly, malaise, neutrophil count decreased. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, CLARITHROMYCIN, METRONIDAZOLE. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Oct 12, 2006. Male patient, 61 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood creatine phosphokinase increased, diarrhoea, hypokalaemia, muscular weakness, myopathy. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D); PER ORAL. During the same period patient was treated with ASPIRIN, PLETAAL, MUCOSTA, FERROMIA, MAGNESIUM OXIDE, ADALAT. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported LANSOPRAZOLE problem on Oct 11, 2006. Female patient, 71 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, arthralgia, chapped lips, diplopia, mouth ulceration, myalgia, skin exfoliation, stevens-johnson syndrome. LANSOPRAZOLE dosage: 30 MG) PER ORAL. During the same period patient was treated with ASPIRIN, AMLODIPINE, BISOPROLOL FUMARATE, PERINDOPRIL ERBUMINE, SIMVASTATIN. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from SWEDEN on Oct 17, 2006. Female patient, 33 years of age, was diagnosed with depression and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: colitis ulcerative, condition aggravated, proctitis ulcerative. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with EFFEXOR, CITALOPRAM HYDROBROMIDE, PULMICORT, CLARITIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Oct 18, 2006. Male patient, 58 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, immunosuppression and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, hypertension. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D); PER ORAL. During the same period patient was treated with PROGRAF, PREDNISOLONE, CELLCEPT. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Physician from UNITED KINGDOM on Oct 23, 2006. Male patient, weighting 136.7 lb, was diagnosed with colorectal cancer metastatic and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: dysarthria, gait disturbance, transient ischaemic attack. LANSOPRAZOLE dosage: 80 MG BY MOUTH DAILY. During the same period patient was treated with LARGACTIL, ATENOLOL, PERINDOPRIL ERBUMINE, TEMAZEPAM, CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Oct 19, 2006. Female patient, 60 years of age, was diagnosed with gastric ulcer and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, blood pressure increased, cardiac failure congestive, cardiomegaly, condition aggravated, diabetic nephropathy, dyspnoea. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with MUCOSTA, ADALAT L, BEZATOL, GLIMICRON. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Oct 27, 2006. Female patient, 65 years of age, was diagnosed with reflux oesophagitis, thrombosis prophylaxis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: acidosis, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood pressure decreased, continuous haemodiafiltration, cyanosis, depressed level of consciousness, dyspnoea. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with TICLOPIDINE HYDROCHLORIDE, ASPIRIN, BLOPRESS, ALLOID G, THROMBIN, PREDNISOLONE, LAC B, PERDIPINE. Patient died.
Health Professional from FRANCE reported LANSOPRAZOLE problem on Nov 06, 2006. Female patient, 61 years of age, was diagnosed with musculoskeletal pain and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: balance disorder, fall, vertigo. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with SOLUPRED, ASPIRIN, SOTALOL, VASTAREL. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Physician from JAPAN on Sept 27, 2006. Female patient, 63 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: hyperammonaemia. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with SIGMART, FLUITRAN, ALDACTONE, GASCON, WARFARIN, MUCOSOLVAN. Patient recovered.
Physician from JAPAN reported LANSOPRAZOLE problem on Sept 27, 2006. Female patient, 63 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: coma hepatic, hyperammonaemia. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with SIGMART, FLUITRAN, ALDACTONE, GASCON, WARFARIN, MUCOSOLVAN. Patient recovered.
LANSOPRAZOLE problem was reported by a Health Professional from UNITED KINGDOM on Nov 16, 2006. Male patient was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal carcinoma, gastrointestinal haemorrhage, iron deficiency anaemia. LANSOPRAZOLE dosage: 15 MG (15 MG,1 IN 1 D). Patient recovered.
Health Professional from GERMANY reported LANSOPRAZOLE problem on Nov 17, 2006. Male patient, 47 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal stromal tumour. LANSOPRAZOLE dosage: 30 MG (15 MG,2 IN 1 D). Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 21, 2006. Male patient, 70 years of age, was diagnosed with barrett's oesophagus, hypertension and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia, thrombotic stroke. LANSOPRAZOLE dosage: 15 MG (15 MG,1 IN 1 D) ORAL. During the same period patient was treated with PROPRANOLOL, ASCORBIC ACID, CETIRIZINE, THIAMINE. Patient died.
Consumer or non-health professional from FRANCE reported LANSOPRAZOLE problem on Nov 30, 2006. Female patient, 84 years of age, was diagnosed with tremor, ballismus, huntington's chorea and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: ballismus, cardiac failure, fatigue, haemorrhagic stroke, movement disorder. LANSOPRAZOLE dosage: 14 MG (1 D); PER ORAL. During the same period patient was treated with SERMION, MODOPAR, XENAZINE, STILNOX, TRIVASTAL. Patient died.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from GERMANY on Nov 29, 2006. Male patient, 47 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: no adverse effect. LANSOPRAZOLE dosage: 30 MG (15 MG,2 IN 1 D). Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Nov 30, 2006. Male patient, 78 years of age, was diagnosed with gastrointestinal haemorrhage and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, diabetic nephropathy, disease progression, renal impairment. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D). During the same period patient was treated with FERROUS CITRATE, AMINOFLUID, LACTEC. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 05, 2006. Female patient, 57 years of age, was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: vision blurred. LANSOPRAZOLE dosage: 30 MG (30 MG,1 IN 1 D). During the same period patient was treated with EPILIM, LEVOTHYROXINE, PREMPAK, VENTOLIN, SYMBICORT. Patient recovered.
Consumer or non-health professional from FRANCE reported LANSOPRAZOLE problem on Dec 05, 2006. Male patient, 79 years of age, was diagnosed with atrial fibrillation, bronchitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: haemoptysis, international normalised ratio increased, overdose, prothrombin level decreased. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D). During the same period patient was treated with PREVISCAN, PROZAC, KETEK, SOLU MEDROL, PULMICORT, BRONCHODUAL. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Health Professional from UNITED KINGDOM on Dec 05, 2006. Male patient was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal carcinoma, gastrointestinal haemorrhage, iron deficiency anaemia. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. Patient recovered.
Consumer or non-health professional from FRANCE reported LANSOPRAZOLE problem on Dec 26, 2006. Male patient, 79 years of age, was diagnosed with atrial fibrillation, bronchitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: bronchitis, haemoptysis, iatrogenic injury, international normalised ratio increased, overdose, prothrombin level decreased. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D)/DAYS. During the same period patient was treated with PREVISCAN, PROZAC, KETEK, SOLU MEDROL, PULMICORT, BRONCHODUAL. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on June 29, 2007. Female patient, 72 years of age, was diagnosed with reflux oesophagitis, infection prophylaxis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cyanosis, diarrhoea, disseminated intravascular coagulation, extrasystoles, feeding tube complication, heart rate increased, moaning, oedema peripheral, platelet count decreased. LANSOPRAZOLE dosage: 60 MG (30 MG, 2 IN 1 D). During the same period patient was treated with TAKEPON, UNASYN S, CHLORIDE, POTASSIUM CHLORIDE, LASIX, BIOFERMIN R, FRANDOL TAPE S. Patient was hospitalized. Patient recovered.
Physician from SWITZERLAND reported LANSOPRAZOLE problem on July 05, 2007. Female patient was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial. LANSOPRAZOLE dosage: unknown. Patient recovered.
LANSOPRAZOLE problem was reported by a Physician from JAPAN on July 05, 2007. Male patient, 70 years of age, was diagnosed with cardiac failure, constipation and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with LASIX, ARTIST, RENIVACE, AMLODIN, MAGMIT, ALDACTONE, ASPIRIN, TICLOPIDINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on July 10, 2007. Male patient, 62 years of age, was diagnosed with gastritis erosive, reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus enterocolitis, interstitial lung disease, nasopharyngitis, pneumocystis jiroveci pneumonia, rash, respiratory failure, small intestinal perforation. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with RABEPRAZOLE. Patient was hospitalized. Patient died.
LANSOPRAZOLE problem was reported by a Physician from JAPAN on July 17, 2007. Male patient, 70 years of age, was diagnosed with constipation and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with LASIX, ARTIST, ENALAPRIL MALEATE, AMLODIPINE, MAGMIT, ALDACTONE, BAYASPIRIN, TICLOPIDINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported LANSOPRAZOLE problem on July 12, 2007. Female patient, 43 years of age, was diagnosed with gastric ulcer, gastrooesophageal reflux disease and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: palpitations, rash, vision blurred. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. Patient recovered.
LANSOPRAZOLE problem was reported by a Health Professional from UNITED KINGDOM on July 12, 2007. Female patient, 85 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: eye pain. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with ASPIRIN, SERETIDE EVOHALER, SIMVASTATIN. Patient recovered.
Consumer or non-health professional from DENMARK reported LANSOPRAZOLE problem on July 23, 2007. Male patient, 73 years of age, was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: headache, vision blurred. LANSOPRAZOLE dosage: 15-30 MG ( UNK, 1-2 CAPSULES), PER ORAL. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from ITALY on Aug 03, 2007. Female patient, 85 years of age, was diagnosed with abdominal pain upper, diabetic neuropathy, psychomotor hyperactivity and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, gait disturbance, pain, renal failure acute, respiratory failure, rhabdomyolysis, somnolence. LANSOPRAZOLE dosage: 30 MG. During the same period patient was treated with GABAPENTIN, HALOPERIDOL, INSULIN LISPRO, RAMIPRIL, ASPIRIN, DILTIAZEM. Patient died.
Consumer or non-health professional from GERMANY reported LANSOPRAZOLE problem on Aug 20, 2007. Male patient was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: glaucoma. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with SORTIS, DELIX, CONCOR, TRAMADOL, MARCUMAR, MUSARIL. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Aug 28, 2007. Female patient, 74 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: constipation, cryptogenic organising pneumonia, nausea. LANSOPRAZOLE dosage: 15 MG (15 MG,1 IN 1 D), PER ORAL. During the same period patient was treated with GASMOTIN. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported LANSOPRAZOLE problem on Aug 28, 2007. Male patient, 72 years of age, was diagnosed with thrombosis prophylaxis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardiac failure acute. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with LIPITOR, ARTIST, NORVASC, PLAVIX. Patient died on 08/13/2007.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2007. Male patient, 71 years of age, was diagnosed with gastric ulcer, reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, condition aggravated, continuous haemodiafiltration, electroencephalogram abnormal, hepatic encephalopathy, hepatic failure, hyperammonaemia, hypoglycaemia, renal failure. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with ITOROL, CARVEDILOL, MUCOSTA, FOIPAN, SIGMART, ALLOPURINOL, LASIX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Sept 07, 2007. Female patient, 75 years of age, was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: haemorrhage subcutaneous. LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with WARFARIN, ESTAZOLAM, LIVALO, AMLODIN OD, FLUVOXAMINE MALEATE, SEDIEL, LENDORMIN, BIOFERMIN. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2007. Male patient, 62 years of age, was diagnosed with erosive duodenitis, gastritis erosive, reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus enterocolitis, dermatitis atopic, immunosuppression, interstitial lung disease, nasopharyngitis, pneumocystis jiroveci pneumonia, rash, respiratory failure, small intestinal perforation. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with RABEPRAZOLE, MYSER. Patient was hospitalized. Patient died.
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Aug 30, 2007. Male patient was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: laryngeal cancer. LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. Patient was hospitalized. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from GERMANY on Sept 05, 2007. Male patient, 69 years of age, was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: jaundice, pancreatic carcinoma. LANSOPRAZOLE dosage: 30 MG PER ORAL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported LANSOPRAZOLE problem on Sept 17, 2007. Male patient, 70 years of age, weighting 187.4 lb, was diagnosed with aneurysm and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: muscle spasms. LANSOPRAZOLE dosage: unknown. During the same period patient was treated with CARVEDILOL, CANDESARTAN CILEXETIL, CLOPIDOGREL. Patient recovered.
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from GERMANY on Sept 14, 2007. Male patient, 69 years of age, was diagnosed with reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, bile duct stenosis, blood pressure decreased, cholelithiasis, dilatation atrial, diverticulum intestinal, ejection fraction decreased, hepatic steatosis. LANSOPRAZOLE dosage: 30 MG PER ORAL. During the same period patient was treated with HAWTHORN, ALLOPURINOL, GODAMED, TALCID, PASPERTIN, TAMSULOSIN. Patient was hospitalized. Patient recovered.
Showing 1-75 of 137 Next >
This
drug has an active FDA Safety Alert